Jeff Courtney is a General Partner of VenGrowth Capital Partners Inc. He has more than 20 years of experience in the life sciences industry with in-depth
expertise across multiple therapeutic areas in quality assurance, regulatory affairs, business development, marketing and sales. Prior to joining VenGrowth, Jeff
was a Partner and Co-President of the Scientific Advisory Board at CDP Capital -Technology Ventures (formerly CDP Sofinov). Jeff also served as President of
Hospital Pharmaceuticals at Faulding Canada Inc., EVP Marketing and Sales for Pharmascience Inc., and held senior leadership roles with Johnson & Johnson,
Medical Products. He has served as a Director on the boards of multiple Canadian and U.S. life science companies and is currently an active board member of
VisualSonics Inc., Axela Inc., and Zelos Therapeutics Inc.
Jeff Courtney is a General Partner of VenGrowth Capital Partners Inc. He has more than 20 years of experience in the life sciences industry with in-depth
expertise across multiple therapeutic areas in quality assurance, regulatory affairs, business development, marketing and sales. Prior to joining VenGrowth, Jeff
was a Partner and Co-President of the Scientific Advisory Board at CDP Capital -Technology Ventures (formerly CDP Sofinov). Jeff also served as President of
Hospital Pharmaceuticals at Faulding Canada Inc., EVP Marketing and Sales for Pharmascience Inc., and held senior leadership roles with Johnson & Johnson,
Medical Products. He has served as a Director on the boards of multiple Canadian and U.S. life science companies and is currently an active board member of
VisualSonics Inc., Axela Inc., and Zelos Therapeutics Inc.
